Literature DB >> 11427608

Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.

M P Weinstein1.   

Abstract

Although imipenem has in vitro activity against Enterococcus faecalis and Food and Drug Administration-approved indications for treatment of infections caused by this microorganism, there are no NCCLS guidelines for susceptibility testing of imipenem versus enterococci. Therefore, the in vitro activities of penicillin, ampicillin, imipenem, and vancomycin against 201 blood isolates of E. faecalis and 24 blood isolates of Enterococcus faecium were compared. The susceptibility of isolates to penicillin or ampicillin accurately predicted the in vitro activity of imipenem. Since the susceptibility of enterococci to imipenem can be predicted by the results obtained by testing of penicillin or ampicillin, testing of imipenem by clinical laboratories probably is not necessary.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11427608      PMCID： PMC88224          DOI： 10.1128/JCM.39.7.2729-2731.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  5 in total

1.  Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

2.  Tentative interpretive criteria for in vitro antibacterial susceptibility testing with imipenem.

Authors:  D L Shungu; A T Cerami; E Weinberg; T Capizzi; H H Gadebusch
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

3.  Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.

Authors:  G M Eliopoulos; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

4.  In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.

Authors:  V W Horadam; J D Smilack; C L Montgomery; J Werringloer
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

5.  Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates.

Authors:  D L Cohn; L G Reimer; L B Reller
Journal:  J Antimicrob Chemother       Date:  1982-03       Impact factor: 5.790
  5 in total
  11 in total

1.  Ampicillin-sensitive, imipenem-resistant strains of Enterococcus faecium.

Authors:  Nagwa El Amin; Bengt Wretlind; Aline Wenger; Valérie Brandt; Jacques Bille
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Prediction of enterococcal imipenem susceptibility using ampicillin or penicillin MICs: more evidence for a class concept.

Authors:  R N Jones
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

3.  Five-Year Antimicrobial Susceptibility Trends Among Bacterial Isolates from a Tertiary Health-Care Facility in Kigali, Rwanda.

Authors:  Makeda Carroll; Ashok Rangaiahagari; Emmanuel Musabeyezu; Donald Singer; Onyema Ogbuagu
Journal:  Am J Trop Med Hyg       Date:  2016-10-31       Impact factor: 2.345

Review 4.  Resistance in Vancomycin-Resistant Enterococci.

Authors:  William R Miller; Barbara E Murray; Louis B Rice; Cesar A Arias
Journal:  Infect Dis Clin North Am       Date:  2020-12       Impact factor: 5.982

5.  Ampicillin susceptibility can predict in vitro susceptibility of penicillin-resistant, ampicillin-susceptible Enterococcus faecalis Isolates to amoxicillin but not to imipenem and piperacillin.

Authors:  Natália Conceição; Cristina da Cunha Hueb Barata de Oliveira; Lucas Emanuel Pinheiro da Silva; Laís Rezende Cardoso de Souza; Adriana Gonçalves de Oliveira
Journal:  J Clin Microbiol       Date:  2012-08-15       Impact factor: 5.948

6.  Prospective Observational Study of the Clinical Prognoses of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis.

Authors:  Dokyun Kim; Hyukmin Lee; Eun-Jeong Yoon; Jun Sung Hong; Jong Hee Shin; Young Uh; Kyeong Seob Shin; Jeong Hwan Shin; Young Ah Kim; Yoon Soo Park; Seok Hoon Jeong
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

Review 7.  Antimicrobial Susceptibility Testing for Enterococci.

Authors:  Ayesha Khan; William R Miller; Dierdre Axell-House; Jose M Munita; Cesar A Arias
Journal:  J Clin Microbiol       Date:  2022-06-13       Impact factor: 11.677

8.  Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy.

Authors:  Graeme N Forrest; Mary-Claire Roghmann; Latoya S Toombs; Jennifer K Johnson; Elizabeth Weekes; Durry P Lincalis; Richard A Venezia
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

9.  Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem.

Authors:  Melvin P Weinstein; Stanley Mirrett; Saman Kannangara; Jan Monahan; Lizzie J Harrell; Alan C Wilson; L Barth Reller
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  An in vitro study on the effects of nisin on the antibacterial activities of 18 antibiotics against Enterococcus faecalis.

Authors:  Zhongchun Tong; Yuejiao Zhang; Junqi Ling; Jinglei Ma; Lijia Huang; Luodan Zhang
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.